PAM
EW icon

Premier Asset Management’s Edwards Lifesciences EW Stock Holding History

Premier Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,960
Closed -$669K – 37
2022
Q4 		$669K Buy
8,960
+4,197
+88% +$323K 0.84% 39
2022
Q3 		$394K Buy
+4,763
New +$458K 0.41% 54

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Premier Asset Management's EW Position: Q1 2023 in Review

Premier Asset Management sold out of Edwards Lifesciences (EW) in Q1 2023, closing a stake of 8,960 shares — an estimated $669K sold.

Premier Asset Management first reported a position in EW in Q3 2022 and held it in 2 quarters. The position peaked at $669K in Q4 2022. 1,246 funds tracked by Wall St. Rank hold EW as of Q1 2023.

  • Premier Asset Management reported no remaining Edwards Lifesciences position as of Q1 2023 after selling out during the quarter.
  • Premier Asset Management sold 8,960 Edwards Lifesciences shares in Q1 2023, an estimated $669K.
  • Premier Asset Management first reported a position in Edwards Lifesciences in Q3 2022 and held it in 2 quarters.
  • Premier Asset Management's Edwards Lifesciences position peaked at $669K in Q4 2022.
  • 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2023.

Based on Premier Asset Management's 13F filing for Q1 2023.